Cargando…

The Role of the Gluten-Free Diet in the Management of Seronegative Enteropathy

The differential diagnosis and treatment of seronegative enteropathy, also termed seronegative villous atrophy (SNVA), is a clinical challenge. Although seronegative coeliac disease (CD) is a frequent cause of SNVA, the aetiology can include immune-mediated, inflammatory, infectious, and drug-relate...

Descripción completa

Detalles Bibliográficos
Autor principal: Szaflarska-Popławska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619095/
https://www.ncbi.nlm.nih.gov/pubmed/34836279
http://dx.doi.org/10.3390/nu13114027
_version_ 1784604906978541568
author Szaflarska-Popławska, Anna
author_facet Szaflarska-Popławska, Anna
author_sort Szaflarska-Popławska, Anna
collection PubMed
description The differential diagnosis and treatment of seronegative enteropathy, also termed seronegative villous atrophy (SNVA), is a clinical challenge. Although seronegative coeliac disease (CD) is a frequent cause of SNVA, the aetiology can include immune-mediated, inflammatory, infectious, and drug-related forms. As a misdiagnosis of SNVA can result in patients being unnecessarily placed on a lifelong strict gluten-free diet or even given incorrect immunosuppressive therapy, the aim of this paper is to provide an evidence-based and practical approach for the workup and management of SNVA.
format Online
Article
Text
id pubmed-8619095
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86190952021-11-27 The Role of the Gluten-Free Diet in the Management of Seronegative Enteropathy Szaflarska-Popławska, Anna Nutrients Review The differential diagnosis and treatment of seronegative enteropathy, also termed seronegative villous atrophy (SNVA), is a clinical challenge. Although seronegative coeliac disease (CD) is a frequent cause of SNVA, the aetiology can include immune-mediated, inflammatory, infectious, and drug-related forms. As a misdiagnosis of SNVA can result in patients being unnecessarily placed on a lifelong strict gluten-free diet or even given incorrect immunosuppressive therapy, the aim of this paper is to provide an evidence-based and practical approach for the workup and management of SNVA. MDPI 2021-11-11 /pmc/articles/PMC8619095/ /pubmed/34836279 http://dx.doi.org/10.3390/nu13114027 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Szaflarska-Popławska, Anna
The Role of the Gluten-Free Diet in the Management of Seronegative Enteropathy
title The Role of the Gluten-Free Diet in the Management of Seronegative Enteropathy
title_full The Role of the Gluten-Free Diet in the Management of Seronegative Enteropathy
title_fullStr The Role of the Gluten-Free Diet in the Management of Seronegative Enteropathy
title_full_unstemmed The Role of the Gluten-Free Diet in the Management of Seronegative Enteropathy
title_short The Role of the Gluten-Free Diet in the Management of Seronegative Enteropathy
title_sort role of the gluten-free diet in the management of seronegative enteropathy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619095/
https://www.ncbi.nlm.nih.gov/pubmed/34836279
http://dx.doi.org/10.3390/nu13114027
work_keys_str_mv AT szaflarskapopławskaanna theroleoftheglutenfreedietinthemanagementofseronegativeenteropathy
AT szaflarskapopławskaanna roleoftheglutenfreedietinthemanagementofseronegativeenteropathy